These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 30001781)

  • 1. Pharmacotherapy Pearls in Rheumatology for the Care of Older Adult Patients: Focus on Oral Disease-Modifying Antirheumatic Drugs and the Newest Small Molecule Inhibitors.
    Betancourt BY; Biehl A; Katz JD; Subedi A
    Rheum Dis Clin North Am; 2018 Aug; 44(3):371-391. PubMed ID: 30001781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapy Pearls for the Geriatrician: Focus on Oral Disease-Modifying Antirheumatic Drugs Including Newer Agents.
    Biehl AJ; Katz JD
    Clin Geriatr Med; 2017 Feb; 33(1):1-15. PubMed ID: 27886691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proposal for a new nomenclature of disease-modifying antirheumatic drugs.
    Smolen JS; van der Heijde D; Machold KP; Aletaha D; Landewé R
    Ann Rheum Dis; 2014 Jan; 73(1):3-5. PubMed ID: 24072562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists.
    van Roon EN; van den Bemt PM; Jansen TL; Houtman NM; van de Laar MA; Brouwers JR
    Clin Ther; 2009 Aug; 31(8):1737-46. PubMed ID: 19808132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutropenia in the Elderly: A Rheumatology Perspective.
    Yeoh SA; Fox C; Hull R
    Drugs Aging; 2016 Aug; 33(8):585-601. PubMed ID: 27402172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tofacitinib in combination with nonbiologic disease-modifying antirheumatic drugs in patients with active rheumatoid arthritis: a randomized trial.
    Kremer J; Li ZG; Hall S; Fleischmann R; Genovese M; Martin-Mola E; Isaacs JD; Gruben D; Wallenstein G; Krishnaswami S; Zwillich SH; Koncz T; Riese R; Bradley J
    Ann Intern Med; 2013 Aug; 159(4):253-61. PubMed ID: 24026258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antirheumatic drugs in older adults and polypharmacy issues.
    Coskun Benlidayi I; Gokce Kutsal Y
    Z Gerontol Geriatr; 2022 Oct; 55(6):507-512. PubMed ID: 34114088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
    Goodman SM; Springer B; Guyatt G; Abdel MP; Dasa V; George M; Gewurz-Singer O; Giles JT; Johnson B; Lee S; Mandl LA; Mont MA; Sculco P; Sporer S; Stryker L; Turgunbaev M; Brause B; Chen AF; Gililland J; Goodman M; Hurley-Rosenblatt A; Kirou K; Losina E; MacKenzie R; Michaud K; Mikuls T; Russell L; Sah A; Miller AS; Singh JA; Yates A
    J Arthroplasty; 2017 Sep; 32(9):2628-2638. PubMed ID: 28629905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Institute of Rheumatology and progress of antirheumatic therapy].
    Sigidin IaA
    Vestn Ross Akad Med Nauk; 1998; (12):7-9. PubMed ID: 9987950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
    Goodman SM; Springer B; Guyatt G; Abdel MP; Dasa V; George M; Gewurz-Singer O; Giles JT; Johnson B; Lee S; Mandl LA; Mont MA; Sculco P; Sporer S; Stryker L; Turgunbaev M; Brause B; Chen AF; Gililland J; Goodman M; Hurley-Rosenblatt A; Kirou K; Losina E; MacKenzie R; Michaud K; Mikuls T; Russell L; Sah A; Miller AS; Singh JA; Yates A
    Arthritis Rheumatol; 2017 Aug; 69(8):1538-1551. PubMed ID: 28620948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease-modifying antirheumatic drugs.
    Conaghan PG; Lehmann T; Brooks P
    Curr Opin Rheumatol; 1997 May; 9(3):183-90. PubMed ID: 9204252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rheumatic Disease Clinics of North America. Drug safety: managing innovation in rheumatology. Foreword.
    Weisman MH
    Rheum Dis Clin North Am; 2012 Nov; 38(4):ix-x. PubMed ID: 23137584
    [No Abstract]   [Full Text] [Related]  

  • 13. Rheumatic diseases and pregnancy: a national survey about practice patterns among rheumatologists and obstetricians.
    Fayad F; Ziade N; Karam GA; Ghaname W; Khamashta M
    Clin Exp Rheumatol; 2018; 36(6):1014-1021. PubMed ID: 29846160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in targeted therapies XII. Preface.
    Breedveld FC; Kalden JR; Smolen JS
    Ann Rheum Dis; 2011 Mar; 70 Suppl 1():i1. PubMed ID: 21339210
    [No Abstract]   [Full Text] [Related]  

  • 15. Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial.
    van Vollenhoven RF; Ernestam S; Geborek P; Petersson IF; Cöster L; Waltbrand E; Zickert A; Theander J; Thörner A; Hellström H; Teleman A; Dackhammar C; Akre F; Forslind K; Ljung L; Oding R; Chatzidionysiou A; Wörnert M; Bratt J
    Lancet; 2009 Aug; 374(9688):459-66. PubMed ID: 19665644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proceedings of the XIIth International Symposium on Advances in Targeted Therapies. April 14-18, 2010.
    Ann Rheum Dis; 2011 Mar; 70 Suppl 1():i1-122. PubMed ID: 21438187
    [No Abstract]   [Full Text] [Related]  

  • 17. Why is methotrexate the first selection in disease-modifying antirheumatic drug therapy? Comment on the article by Wolfe et al.
    Caballero-Uribe CV
    Arthritis Care Res; 1999 Apr; 12(2):152. PubMed ID: 10513503
    [No Abstract]   [Full Text] [Related]  

  • 18. Putting recommendations into practice: Australian rheumatologists' opinions on leflunomide use in rheumatoid arthritis.
    Hopkins AM; Wiese MD; O'Doherty CE; Proudman SM
    Clin Rheumatol; 2017 Apr; 36(4):791-798. PubMed ID: 27888342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practical Pearls About Current Rheumatic Medications.
    Ward IM; Knott A
    Prim Care; 2018 Jun; 45(2):193-212. PubMed ID: 29759120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on the use of conventional disease-modifying antirheumatic drugs in the management of rheumatoid arthritis.
    Feely MG; O'Dell JR
    Curr Opin Rheumatol; 2010 May; 22(3):316-20. PubMed ID: 20190639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.